AEON Biopharma, Inc. (AEON) — Long-term Investment Intensity
AEON Biopharma, Inc. (AEON) has a Long-term Investment Intensity of 1.2% as of December 2019. Long-term investments of $1.43 Million represent 1.2% of total assets of $114.35 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See net assets of AEON Biopharma, Inc. for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AEON Biopharma, Inc. Long-term Investment Intensity (2019–2019)
This chart shows how AEON Biopharma, Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2019 to 2019. As of December 2019, the intensity stands at 1.2%, reflecting long-term investments of $1.43 Million against total assets of $114.35 Million USD. Also explore balance sheet size of AEON Biopharma, Inc. for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for AEON Biopharma, Inc. (2019–2019)
The table below presents the year-by-year Long-term Investment Intensity for AEON Biopharma, Inc. from 2019 to 2019, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AEON Biopharma, Inc. (AEON) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.2% | $1.43 Million | $114.35 Million | — |